Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3258669 | 0.86 | — | — | |
| SCHEMBL7680456 | 0.82 | — | — | |
| SCHEMBL1072391 | 0.82 | — | — | |
| Bicarbonate SCHEMBL3263561 | 0.80 | MAPT (0.33) | MAPTKMT2AALDH1A1LMNAHPGD | |
| SCHEMBL2204103 | 0.77 | — | — | |
| SCHEMBL28621500 | 0.76 | USP2 (0.38) | USP2MAPTKMT2AALDH1A1LMNA | |
| SCHEMBL5792071 | 0.76 | MAPT (0.39) | USP2MAPTKMT2AALDH1A1LMNA | |
| SCHEMBL861620 | 0.75 | FDPS (0.36) | KMT2A | |
| SCHEMBL18628045 | 0.75 | FDPS (0.36) | KMT2A | |
| SCHEMBL19559990 | 0.75 | FDPS (0.36) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240074437-A1 | SURFACE ANTIMICROBIAL TREATMENTS | Crossing S.r.l. (IT) | 2024-03-07 | — | — | US | claimed |
| EP-4258879-A1 | SURFACE ANTIMICROBIAL TREATMENTS | Crossing S.r.l. (IT) | 2023-10-18 | — | — | EP | claimed |
| CN-116583569-A | Surface antimicrobial treatment | 克罗星有限公司 | 2023-08-11 | — | — | CN | claimed |
| WO-2022123441-A1 | SURFACE ANTIMICROBIAL TREATMENTS | Crossing S.r.l. (IT) | 2022-06-16 | — | — | WO | claimed |
| EP-2179001-A1 | A LIQUID COMPOSITION SUITABLE FOR USE AS A CORROSION INHIBITOR AND METHOD FOR ITS PREPARATION | Bromine Compounds Ltd. (IL) | 2010-04-28 | — | — | EP | claimed |
| US-20090050853-A1 | Liquid composition suitable for use as a corrosion inhibitor and a method for its preparation | BROMINE COMPOUNDS LTD. (IL) | 2009-02-26 | — | — | US | claimed |
| WO-2009022332-A1 | A LIQUID COMPOSITION SUITABLE FOR USE AS A CORROSION INHIBITOR AND METHOD FOR ITS PREPARATION | BROMINE COMPOUNDS LTD. (IL) | 2009-02-19 | — | — | WO | claimed |
| US-4391721-A | Dispersant viscosity index improver comprising reaction product of a styrene-maleic anhydride copolymer, an aliphatic alcohol and a tertiary amino alcohol | STANDARD OIL COMPANY (INDIANA) (US) | 1983-07-05 | — | — | US | claimed |
| US-4179423-A | TERTIARY AMINE, TRIOL, TRICARBOXYLIC ACID ANHYDRIDE | SCHENECTADY CHEMICALS, INC. (US) | 1979-12-18 | — | — | US | claimed |
| US-4103087-A | REACTING TERTIARY AMINOALKANOL WITH A SECONDARY AMINE IN PRESENCE OF AN ALUMINUM PHOSPHATE CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1978-07-25 | — | — | US | claimed |
| US-4095022-A | PHOSPHORUS COMPOUNDS, SILICA-ALUMINA CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1978-06-13 | — | — | US | claimed |
| US-4026935-A | FROM N-(HYDROXYALKYL)-MORPHOLINE COMPOUND, SILICA-ALUMINA CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1977-05-31 | — | — | US | claimed |
| US-20240074437-A1 | SURFACE ANTIMICROBIAL TREATMENTS | Crossing S.r.l. (IT) | 2024-03-07 | — | — | US | disclosed |
| EP-4258879-A1 | SURFACE ANTIMICROBIAL TREATMENTS | Crossing S.r.l. (IT) | 2023-10-18 | — | — | EP | disclosed |
| CN-116583569-A | Surface antimicrobial treatment | 克罗星有限公司 | 2023-08-11 | — | — | CN | disclosed |
| WO-2022123441-A1 | SURFACE ANTIMICROBIAL TREATMENTS | Crossing S.r.l. (IT) | 2022-06-16 | — | — | WO | disclosed |
| US-4048338-A | Aqueous cosmetic composition containing amine oxides | COLGATE-PALMOLIVE COMPANY (US) | 1977-09-13 | — | — | US | disclosed |
| US-4026935-A | FROM N-(HYDROXYALKYL)-MORPHOLINE COMPOUND, SILICA-ALUMINA CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1977-05-31 | — | — | US | disclosed |
| US-4026935-A | FROM N-(HYDROXYALKYL)-MORPHOLINE COMPOUND, SILICA-ALUMINA CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1977-05-31 | — | — | US | disclosed |
| US-4018723-A | Morpholino-modified polysiloxane-polyoxyalkylene copolymers and their use as foam stabilizers in polyurethanes | UNION CARBIDE CORPORATION (US) | 1977-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240074437-A1 | SURFACE ANTIMICROBIAL TREATMENTS | CUTA, ETF1, SFN | USP2 819/4885MAPT 3867/4885KMT2A 2007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.